Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals–a comprehensive review

L Padrela, MA Rodrigues, A Duarte, AMA Dias… - Advanced drug delivery …, 2018 - Elsevier
Low drug bioavailability, which is mostly a result of poor aqueous drug solubilities and of
inadequate drug dissolution rates, is one of the most significant challenges that …

Supercritical antisolvent process for pharmaceutical applications: A review

P Franco, I De Marco - Processes, 2020 - mdpi.com
The supercritical antisolvent (SAS) technique has been widely employed in the biomedical
field, including drug delivery, to obtain drug particles or polymer-based systems of …

[图书][B] Handbook of encapsulation and controlled release

M Mishra - 2015 - books.google.com
Written at a level comprehensible to non-experts, this handbook covers the current state of
encapsulation and controlled released technologies, presenting the fundamental processes …

Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: an eco-friendly welcome to active pharmaceutical ingredients (APIs)

RK Kankala, PY Xu, BQ Chen, SB Wang… - Advanced Drug Delivery …, 2021 - Elsevier
Despite the success in developing various pharmaceutical formulations, most of the active
pharmaceutical ingredients (APIs)/drugs, according to the Biopharmaceutics Classification …

[HTML][HTML] Studies on the spray dried lactose as carrier for dry powder inhalation

L Wu, X Miao, Z Shan, Y Huang, L Li, X Pan… - asian journal of …, 2014 - Elsevier
The purpose of this study was to investigate the spray dried lactose as carrier for dry powder
inhalation (DPI). The lactose particles were prepared by spray drying, then the particle size …

Supercritical antisolvent coprecipitation mechanisms

V Prosapio, I De Marco, E Reverchon - The Journal of Supercritical Fluids, 2018 - Elsevier
Supercritical antisolvent precipitation (SAS) has been successfully used to produce
microparticles and nanoparticles of controlled size and distribution either as a single …

Dry powder inhalable formulations for anti-tubercular therapy

T Parumasivam, RYK Chang, S Abdelghany… - Advanced drug delivery …, 2016 - Elsevier
Tuberculosis (TB) is an intracellular infectious disease caused by the airborne bacterium,
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …

High dose dry powder inhalers to overcome the challenges of tuberculosis treatment

MAM Momin, IG Tucker, SC Das - International journal of pharmaceutics, 2018 - Elsevier
Tuberculosis (TB) is a major global health burden. The emergence of the human
immunodeficiency virus (HIV) epidemic and drug resistance has complicated global TB …

The influence of surface active l-leucine and 1, 2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and …

BB Eedara, B Rangnekar, C Doyle, A Cavallaro… - International journal of …, 2018 - Elsevier
Pharmacotherapy of tuberculosis is potentially more efficient when delivered by the inhaled
route than by the current oral and/or parenteral routes due to the higher concentration of …

Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives

R Kumar, AK Thakur, G Kali, KC Pitchaiah… - Drug Delivery and …, 2023 - Springer
The low aqueous solubility and subsequently slow dissolution rate, as well as the poor
bioavailability of several active pharmaceutical ingredients (APIs), are major challenges in …